Skip to main content
. 2021 Dec 23;7:99. doi: 10.1186/s40798-021-00390-y

Table 1.

Summary of adaptations related to cardiorespiratory fitness, insulin sensitivity, glycemic control, and mitochondrial content following common low-volume interval training protocols in women

Protocol Training duration
2–4 weeks 5–11 weeks 12–16 weeks
Repeated Wingate SIT (3–8 × 30 s) V˙O2peak [44, 68, 70, 161] V˙O2peak [47, 54, 67] V˙O2peak [55]

↓ HbA1c [162

↔ HbA1c [55]

↔ HbA1c [55]

↑ CS protein content [70]

↔ CS maximal activity [163]

↔ COXIV protein content [70]

HIIT

(10–12 × 1 min)

V˙O2peak [46, 49, 64, 79]

V˙O2peak [164]

V˙O2peak [49, 50, 165] V˙O2peak [49]

↔ OGTT insulin sensitivity [50]

↓ HOMA-IR [166]

↓ HOMA-IR [110]

↑ CS maximal activity [50]

↑ COX activity [121]

Repeated sprint SIT

(6–20 s efforts)

V˙O2peak [60, 167] V˙O2peak [51, 61, 63, 65, 66, 168]

↓ HOMA-IR [61]

↔ HOMA-IR [65, 66]

↓ HbA1c [100]

↔ HbA1c [66]

Reduced-volume SIT

(≤ 10 min session)

V˙O2peak [62, 72]

V˙O2peak [75]

V˙O2peak [52, 53, 69, 71, 75] V˙O2peak [10, 75]

↔ OGTT insulin sensitivity [69, 71]

↔ 24 h glucose mean or AUC [53]

↓ HOMA-IR [53]

↔ HOMA-IR [10]

↑ CS maximal activity [53]

↑ COXIV protein content [53]

Reduced-volume HIIT (5 × 1 min) V˙O2peak [73, 76]

↔ OGTT glucose and insulin AUC [73]

↓ HOMA-IR [76]

↔ HbA1c [73]

↑ mitochondrial complex I, II, III, IV and V protein content [138]

↑ CS maximal activity [138]

Studies were conducted in women who were classified as healthy [10, 46, 47, 49, 52, 54, 65, 6972, 75, 79, 161], with overweight/obesity [44, 50, 51, 53, 55, 6063, 66, 67, 73, 76, 100, 110, 121, 138, 162, 164, 167, 168] and/or type 2 diabetes [100, 162]. For transparency, the same cohort of women was examined in the following pairs of references: [50, 121] and [73, 138]. The symbol (†) denotes when a finding has only been documented in a study comparing responses between sexes and is based on a main effect of time for both men and women. Abbreviations: increase; decrease; ↔ no change; AUC area under the curve; COXIV cytochrome c oxidase subunit IV; CS citrate synthase; HbA1c glycated hemoglobin; HOMA-IR homeostatic model assessment of insulin resistance; OGTT oral glucose tolerance test; V˙O2peak peak oxygen uptake